China channel feed

Small transpa­cif­ic team led by Lil­ly, Ever­est vet turns to com­pu­ta­tion­al tools for next wave of pep­tide drug dis­cov­ery

18 hours ago
Financing
Startups

BioN­Tech grabs PD-L1/VEGF bis­pe­cif­ic with $55M up­front, ex­pand­ing pipeline while low­er­ing Covid guid­ance

4 weeks ago
Deals

FDA green­lights first made-in-Chi­na PD-1 as Jun­shi, Co­herus beat BeiGene to the punch

Last month
FDA+

Dana­her’s third-quar­ter rev­enue from biotech ser­vices down 19% amid slow­down in Chi­na, US

Last month
Outsourcing
Pharma

Mer­ck ax­es two of nine AD­Cs in pact with Kelun-Biotech

Last month
Deals
Pharma

BioN­Tech sends $70M to an­oth­er ADC part­ner to go up against Dai­ichi Sankyo in HER3

Last month
Deals
Pharma

Sanofi adds an­oth­er AI al­liance, this time for bi­o­log­ics with Baidu CEO’s start­up

Last month
Deals
AI

Up­dat­ed: GSK taps Chi­nese part­ner to ramp up Shin­grix sales in $3.05B deal, with op­tion to ex­pand to RSV

Last month
Deals

Chi­nese cell ther­a­py biotech de­vel­op­ing TIL ther­a­pies rais­es $60M Se­ries B

2 months ago
Financing

AB­VC Bio­Phar­ma to break ground in Chi­na, ad­vances 20% stake in Zhonghui re­al es­tate 

3 months ago
R&D

In­no­force names De­wan Zeng as the new CEO

4 months ago
People
Manufacturing

Mer­ck KGaA, Mil­li­pore­Sig­ma make in­vest­ments in the US and Chi­na man­u­fac­tur­ing

4 months ago
Manufacturing

Up­dat­ed: FDA to im­port more of com­mon can­cer drug from Chi­na af­ter In­di­an site clo­sure

4 months ago
Pharma
Manufacturing

BeiGene fur­ther in­vests in AD­Cs with sol­id tu­mor part­ner Du­al­i­ty­Bio, a BioN­Tech col­lab­o­ra­tor

4 months ago
Startups
Deals

WuXi Bi­o­log­ics seeks spin­out, HK list­ing of bio­con­ju­gates-fo­cused joint ven­ture

4 months ago
Financing
Outsourcing

Chi­na ap­proves BC­MA CAR-T ther­a­py for mul­ti­ple myelo­ma, with In­novent beat­ing Leg­end in race to be first

5 months ago
Cell/Gene Tx

CSPC to launch Paxlovid ver­sion in Chi­na; SEC charges ex-Pfiz­er em­ploy­ee with in­sid­er trad­ing

5 months ago
Coronavirus
Law

Tout­ing pro­grams from No­var­tis, Laek­na bags $100M in Hong Kong IPO while Mer­ck-part­nered Kelun seeks up to $208M

5 months ago
Financing

As­traZeneca pon­ders a Chi­na phar­ma spin­off to pro­tect it­self from geopo­lit­i­cal fall­out — FT

5 months ago
Pharma

As­traZeneca en­lists an up­start Chi­na biotech part­ner in the wake of an R&D set­back

5 months ago
Deals
Bioregnum

Ec­co­gene nabs $25M Se­ries B for GLP-1 and a NASH drug can­di­date, as com­peti­tors lap the Chi­na biotech

5 months ago
Financing
Startups

Fo­s­un Phar­ma to re­ceive $100M+ via World Bank for fa­cil­i­ty in Ivory Coast

5 months ago
Pharma
Manufacturing

FDA in­spec­tion of Chi­na-based site mak­ing Co­herus' po­ten­tial new can­cer drug ends with three ob­ser­va­tions

6 months ago
FDA+

Chi­na's mar­ket reg­u­la­tor fines, con­fis­cates rev­enue from phar­mas for mo­nop­o­liz­ing APIs for ep­i­neph­rine

6 months ago
R&D
1234 Next page Last page
A service from the Financial Times